1672PMaintenance treatment with the TLR9 agonist lefitolimod in extensive-stage small-cell lung cancer (ES-SCLC): Final results from the randomized phase II IMPULSE study. (23rd October 2018) - Thomas, M; Ponce Aix, S; Navarro Mendivil, A; Riera Knorrenschild, J; Schmidt, M; Wiegert, E; Kapp, K; Mauri, C; Domine Gomez, M; Kollmeier, J; Sadjadian, P; Fröhling, K-P; et al.